Immunic (IMUX) Retained Earnings (2013 - 2026)
Immunic (IMUX) posted Retained Earnings of -$641.2 million for Q1 2026, down 5.35% sequentially from -$608.6 million in Q4 2025, and down 19.42% YoY from -$795.7 million in Q1 2025.
Immunic (IMUX) Retained Earnings (2013 - 2026) Analysis & Trends
Immunic has reported Retained Earnings for 14 years, with the latest figure at -$641.2 million in Q1 2026.
- Quarterly Retained Earnings fell 19.42% year-over-year to -$641.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$641.2 million (down 19.42% YoY) and the FY2025 annual result came in at -$608.6 million, down 19.01% from the prior year.
- Retained Earnings eased to -$641.2 million in Q1 2026 per IMUX's latest filing, from -$608.6 million in the prior quarter.
- Over five years, Retained Earnings peaked at $430.0 million in Q1 2023 and troughed at -$641.2 million in Q1 2026.
- A 5-year average of -$287.8 million and a median of -$366.6 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings tumbled 32500.0% in 2022, then jumped 138795.16% in 2023.
- Over 5 years, Retained Earnings stood at -$317.3 million in 2022, then dropped by 29.51% to -$410.9 million in 2023, then fell by 24.46% to -$511.4 million in 2024, then retreated by 19.01% to -$608.6 million in 2025, then declined by 5.35% to -$641.2 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$641.2 million, -$608.6 million, and -$589.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 800.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 800.05 Mn |
| Mar 31, 2026 | -641.16 Mn |
| Dec 31, 2025 | -608.60 Mn |
| Sep 30, 2025 | -589.30 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | -536.87 Mn |
| Dec 31, 2024 | -511.40 Mn |
| Sep 30, 2024 | 3.89 Mn |
| Jun 30, 2024 | -461.90 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Dec 31, 2023 | -410.90 Mn |
| Sep 30, 2023 | -389.30 Mn |
| Jun 30, 2023 | -366.55 Mn |
| Mar 31, 2023 | 429.96 Mn |
| Dec 31, 2022 | -317.28 Mn |
| Sep 30, 2022 | -260.80 Mn |
| Jun 30, 2022 | -239.58 Mn |
| Mar 31, 2022 | -310,000.00 |
| Dec 31, 2021 | -196.87 Mn |
| Sep 30, 2021 | -800,000.00 |